Evaluating the Pieces of the Pharma Supply Chain - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Evaluating the Pieces of the Pharma Supply Chain
After a year of increased attention on the pharmaceutical supply chain in Asia, what will be the region's short- and long-term role? This article contains bonus online-exclusive material.


Pharmaceutical Technology
Volume 33, Issue 1

References

1. FDA, "Melamine Contamination in China" (Rockville, MD) Dec. 4, 2008, available at http://www.fda.gov/oc/opacom/hottopics/melamine.html, accessed Dec. 5, 2008.

2. FDA Release, "FDA Detects Melamine Contamination in Flavored Drink" (Rockville, MD), Oct. 6, 2008.

3. FDA, "Pet Food Recall (Melamine)/Tainted Animal Feed" (Rockville, MD), Feb. 6, 2008, available at http://www.fda.gov/oc/opacom/hottopics/petfood.html, accessed Dec. 5, 2008.

4. FDA, "Imported Toothpaste" (Rockville, MD) Oct. 9, 2007, available at http://www.fda.gov/oc/opacom/hottopics/toothpaste.html, accessed Dec. 5, 2008.

5. HHS, FDA Warning Letter to Ranbaxy Laboratories Limited, (Silver Spring, MD), Sept. 16, 2008.

6. PricewaterhouseCoopers, "The Changing Dynamics of Pharma Outsourcing in Asia: Are You Readjusting Your Sights?," (NY, New York), Oct. 2008.

7. P. Van Arnum, "Manufacturing Insights: Pfizer," Pharm. Technol. 32 (7), 50–52 (2008).

8. P. Van Arnum, "Outsourcing R&D in Asia: A Case Study of Pfizer," Pharm. Technol. 32 (8) Outsourcing Resources Suppl., s56–s62 (2008).

9. J. Lechleiter, "Innovation: The Cure for What Ails Us," speech at the Economic Club of Indiana, Sept. 24, 2008.

10. J. Dingell, F. Pallone, Jr., and B. Stupak, "Memorandum to the Members of the Committee on Energy and Commerce," US House of Representatives, Apr. 17, 2008.

11. US House Committee on Energy and Commerce, "Food and Drug Administration Globalization Act," Revised Discussion Draft, July 24, 2008 (Washington, DC).

12. J. Dingell, "Letter to Democratic Caucus" (Washington, DC), Nov. 6, 2008.

13. S. 3633, "Transparency in Drug Labeling Act," US Senate, 110th Congress, 2nd Session (Washington, DC), Sept. 26, 2008.

14. Interagency Working Group on Import Safety, "Import Safety—Action Plan Update, A Report to the President" (Washington, DC), July 1, 2008.

15. FDA, "Agreement between the Department of Health and Human Services of the USA and the State Food and Drug Administration of the People's Republic of China on the Safety of Drugs and Medical Devices" (Rockville, MD), Dec. 11, 2007.

16. HHS, "HHS Announces New International Programs to Enhance Drug and Food Safety" (Washington, DC), July 9, 2008.

17. ICH, Q10 Pharmaceutical Quality System (Geneva, Switzerland, June 2008), available at http://www.ich.org/cache/como/276-254-1.htm, accessed Dec. 10, 2008.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here